← Back to directory

Klaus G. Parhofer

Researcher Next ID · RN-040221

Researcher · Biochemistry, Genetics and Molecular Biology

LMU Klinikum

Munich, Austria

Accepting doctoral researchersFunding unknown
Works count
489
Citation count
19,547
H-index
63
i10-index
180

Research interests

Biochemistry, Genetics and Molecular Biology
Medicine
Lipoproteins and Cardiovascular Health
Diabetes, Cardiovascular Risks, and Lipoproteins
Cancer, Lipids, and Metabolism
Lipid metabolism and disorders
Diabetes Treatment and Management

Publications

  • 2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias

    European Heart Journal · 2025 · https://doi.org/10.1093/eurheartj/ehaf190

  • Frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis Society

    Atherosclerosis · 2023 · 10.1016/j.atherosclerosis.2023.04.012

  • 2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance

    European Heart Journal · 2023 · 10.1093/eurheartj/ehad197

  • Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement

    European Heart Journal · 2022 · https://doi.org/10.1093/eurheartj/ehac361

  • Clinical review on triglycerides

    European Heart Journal · 2019 · 10.1093/eurheartj/ehz785

  • Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement

    The Lancet Diabetes & Endocrinology · 2019 · https://doi.org/10.1016/s2213-8587(19)30264-5

  • HDL cholesterol: reappraisal of its clinical relevance

    Clinical Research in Cardiology · 2017 · https://doi.org/10.1007/s00392-017-1106-1

  • Alirocumab in patients with heterozygous familial hypercholesterolaemia undergoing lipoprotein apheresis: the ODYSSEY ESCAPE trial

    European Heart Journal · 2016 · 10.1093/eurheartj/ehw388

  • Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment

    European Heart Journal · 2015 · https://doi.org/10.1093/eurheartj/ehv157

  • Interaction between Glucose and Lipid Metabolism: More than Diabetic Dyslipidemia

    Diabetes & Metabolism Journal · 2015 · 10.4093/dmj.2015.39.5.353

  • Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation

    Journal of clinical lipidology · 2014 · 10.1016/j.jacl.2014.01.002

  • Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society

    European Heart Journal · 2014 · https://doi.org/10.1093/eurheartj/ehu274

  • Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society

    European Heart Journal · 2014 · https://doi.org/10.1093/eurheartj/ehu274

  • Diabetic dyslipidemia

    Metabolism · 2014 · 10.1016/j.metabol.2014.08.010

  • The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management

    The Lancet Diabetes & Endocrinology · 2013 · https://doi.org/10.1016/s2213-8587(13)70191-8

  • Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation

    International Journal of Cardiology · 2013 · 10.1016/j.ijcard.2013.11.025

  • Current level of glycaemic control and its associated factors in patients with type 2 diabetes across Europe: data from the PANORAMA study

    Clinical Endocrinology · 2012 · https://doi.org/10.1111/cen.12119

  • “European Panel on Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses

    Current Vascular Pharmacology · 2011 · 10.2174/157016111796642661

  • Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein(a) levels and prevent major adverse coronary events

    Nature Reviews Cardiology · 2009 · https://doi.org/10.1038/ncpcardio1456

  • Pericardial Adipose Tissue Determined by Dual Source CT Is a Risk Factor for Coronary Atherosclerosis

    Arteriosclerosis Thrombosis and Vascular Biology · 2009 · https://doi.org/10.1161/atvbaha.108.180653

  • Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis

    European Journal of Endocrinology · 2009 · https://doi.org/10.1530/eje-09-0380

  • Adipokines and Insulin Resistance

    Molecular Medicine · 2008 · https://doi.org/10.2119/2008-00058.rabe

  • Liquid Chromatography Tandem-mass Spectrometry (LC-MS/MS) - Technique and Applications in Endocrinology

    Experimental and Clinical Endocrinology & Diabetes · 2007 · 10.1055/s-2007-981458

  • Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary

    European Heart Journal · 2007 · 10.1093/eurheartj/ehl260

  • Defining high-fat-diet rat models: metabolic and molecular effects of different fat types

    Journal of Molecular Endocrinology · 2006 · 10.1677/jme.1.01909

Current projects

    No projects listed.